# US 2026/0062734 A1 · Test method for mild cognitive impairment, test reagent for mild cognitive impairment, and method for screening therapeutic candidate substances for mild cognitive impairment

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0062734 A1
- Document ID: US20260062734A1
- Status: Published application
- Kind: A1
- Application number: 19/280,075
- Filed: 2025-07-24
- Published: 2026-03-05
- Earliest claimed: 2020-08-18
- Assignees: Bioradical Research Institute Corp.
- Applicants: Bioradical Research Institute Corp.
- Inventors: Masaichi Lee; Tomoko Komatsu
- Web page: https://patentgrep.com/patent/US20260062734A1

## CPC

- C12Q 1/26: involving oxidoreductase
- C12Y 115/01001: Superoxide dismutase (1.15.1.1)
- G01N 33/15: Medicinal preparations {; Physical properties thereof, e.g. dissolubility}
- G01N 33/6896: {Neurological disorders, e.g. Alzheimer's disease}
- C07K 14/435: from animals; from humans
- C12N 9/0004: {Oxidoreductases (1.)}
- G01N 2800/2814: Dementia; Cognitive disorders
- G01N 2800/7009: Oxidative stress
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Y: ENZYMES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Provided is a test method with which mild cognitive impairment (MCI) is detectable and a measurement reagent for use in the test method. A test method for MCI according to the present invention includes a step of measuring the activity of superoxide dismutase (SOD) in a biological sample of a subject.

## Claims

### Claim at position 1

1-7. (canceled)

### Claim 8

A test reagent for MCI, comprising a reagent for measuring activity of SOD.

### Claim 9 (depends on 8)

The test reagent according to claim 8, wherein the measurement reagent contains a probe for detecting xanthine, xanthine oxidase, and superoxide.

### Claim 10 (depends on 8)

The test reagent according to claim 8 for use in a test method for mild cognitive impairment (MCI) comprising measuring activity of superoxide dismutase (SOD) in a biological sample of a subject.

### Claim at position 5

11-15. (canceled)
